US Generic Drug Market 2017 - Teva, Mylan, Actavis, Sandoz, Sun Pharma, Par Pharmaceuticals

The US generic drug market has witnessed a steady growth in the recent years. The major factors that have added to the market growth are low investment in R&D, patent expiry of innovative drugs and cost-effectiveness of generic drugs as compared to their counterparts.

Request a free sample copy of the report: www.imarcgroup.com/request?type=report&id=567&flag=B

The latest report by IMARC Group, titled “US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the US generic drug market reached a value of nearly 4 Million prescriptions in 2016, exhibiting a CAGR of 5% during 2010-2016. Over the past several years, the United States has undergone a major transformation in the pharmaceutical sector. Nearly, 80% of the total prescription drugs in the US consist of generic drugs. They are low-cost versions of the innovator drugs with same dosage, strength, risks, effects, side-effects and intended usage. Generic drugs assure that the medicines are effective and safe for the consumers. These drugs come in different forms such as oral, nebulizer, intravenous, topical and intramuscular.

Highlights of the US generic drug market:

• Upcoming patent expiry of branded drugs is projected to boost the market growth.
• With low manufacturing costs, these drugs are comparatively cheaper than innovative drugs.
• Teva represents the leading manufacturer of generic drugs in the US.

Generic drugs can only be launched by the manufacturers once the branded drugs go off-patent. Imminent patent expiry of a huge number of blockbuster innovator drugs is expected to be one of the major factors contributing to the market growth. Moreover, generic drugs require less effort in the research & development sector, thus the cost involved in the manufacturing of these drugs are lower than the branded drugs. Owing to this, generic drugs are cheaper in comparison to their counterparts, thereby making them affordable for different income groups. This helps in reducing the healthcare expenditures of the government, patients and third-party payers. Additionally, the fact that the US pharmacists are paid incentives to prescribe cheaper generic drugs has further stimulated the market growth. Other major factors fueling the growth of the market include ageing population and prevalence of chronic diseases. According to the report, the market is anticipated to reach a value of around 5 Million prescriptions by 2022.

Read full report with TOC @ www.imarcgroup.com/us-generics-market

The US generic drug market is segmented into branded and unbranded generics. Presently, unbranded generic drugs are leading the market, holding for the majority of the total generic prescription volumes. On comparing the competitive landscape of the market, the key players found are Teva, Mylan, Actavis, Sandoz, Sun Pharma, Par Pharmaceuticals, Endo Pharmaceuticals, Lupin Pharmaceuticals, Dr Reddy’s and Hospira. Among these, Teva represents the leading generic manufacturer in the US, accounting for around a fifth of the total generic sales.

Browse related reports :
GCC Generic Drug Market: www.imarcgroup.com/gcc-generic-drug-market

US Generic Injectables Market: www.imarcgroup.com/us-generic-injectables-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.Global Cigarette Lighter Market

Contact us

IMARC Group
309 2nd St, Brooklyn, NY 11215, USAWebsite: www.imarcgroup.com
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal

Global Cataract Surgical Devices Market 2017: Region Wise Analysis of Top Players in Market By Types and Application

The global cataract surgical devices market has witnessed a steady growth over the years. This can be accredited to the availability of a wide range of modern and innovative ophthalmic devices coupled with an ageing population.

Request sample report: http://www.imarcgroup.com/request?type=report&id=840&flag=B

The latest report by IMARC Group, titled “Cataract Surgical Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global cataract surgical devices market reached a value of nearly US$ 7 Billion in 2016. Cataract is an eye disease in which things appear blurry, hazy or less colourful, resulting in cloudy or opaque vision. It can be caused due to ageing, diabetes, smoking, trauma or prolonged exposure to sunlight. Cataract can be removed using certain surgical instruments and devices, such as ophthalmic viscoelastic devices, drapes, gloves, balanced salt solution, forceps, irrigation set, and intraocular lenses. These devices are safe and help in effectively restoring vision to the eye.

Highlights of the global cataract surgical devices market:

• Rapid increase in the prevalence of ocular disorders is the key factor driving the growth of the market.
• Intraocular lenses are the most popular product type, holding the largest share.
• North America represents the largest market, accounting for the majority of the global share.

A rise in the geriatric population worldwide in confluence with growing prevalence of ocular diseases and technological advancements in the healthcare sector represent the major factors influencing the cataract surgical devices market. On the other hand, a lack of awareness among the individuals regarding the benefits of cataract surgeries along with low healthcare insurance coverage impede the growth of the cataract surgical devices market in the emerging regions. However, the governments of numerous countries are introducing healthcare programmes to reduce the burden of cataract-related diseases on the patients, further creating profitable opportunities for the manufacturers. Owing to these factors, the global cataract surgical devices market is further expected to reach a value of around US$ 9 Billion by 2022, exhibiting a CAGR of nearly 4% during 2017-2022.

The market is segmented on the basis of product type into Intraocular Lenses (IOLs), femtosecond laser, Ophthalmic Viscoelastic Devices (OVDs), phacoemulsification equipment and others. Currently, IOLs represent the most popular product type, accounting for the majority of the market share. On the basis of application, the market is segregated in hospitals, eye care clinics, and eye treatment and surgical centres, wherein hospital accounts for the largest share. On a regional basis, North America currently accounts for the largest share. Other major regions include Europe, Asia Pacific, Latin America, and Middle East and Africa. On evaluating the competitive landscape of the market, it is found that the global players are Abbott Laboratories, Hoya Corporation, Carl Zeiss Meditec, Alcon Laboratories, Inc., and Essilor.

Read full report with TOC: http://www.imarcgroup.com/cataract-surgical-devices-market

The report by IMARC Group has examined the global cataract surgical devices market on the basis of:

Product Type:

• Intraocular Lenses (IOLs) 
• Femtosecond laser 
• Ophthalmic Viscoelastic Devices (OVDs)
• Phacoemulsification Equipment 

Application:

• Hospitals
• Eye Care Clinics
• Eye Treatment and Surgical Centres

Region:

•  North America
•  Europe
•  Asia Pacific
•  Latin America
•  Middle East and Africa

Key Players:

• Abbott Laboratories
• Hoya Corporation
• Carl Zeiss Meditec
• Alcon Laboratories, Inc
• Essilor

Browse related reports:

Eyewear Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Global Sanitary Napkin Market Overview 2017, Demand by Regions, Types and Analysis of Key Players

The global sanitary napkin market has witnessed a healthy growth over the past several years. This can be accredited to growing awareness about feminine hygiene, rising incomes and product versatility.

Request sample report @ http://www.imarcgroup.com/request?type=report&id=825&flag=B

The latest report by IMARC Group titled, “Sanitary Napkin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global sanitary napkin market reached a value of around US$ 14.5 Billion in 2016. Sanitary napkin is widely used by women for menstrual management. It is a thin disposable pad made of materials such as quilted cotton fabrics and layers of super absorbent polymers and plastics. Earlier, women used home-made cotton pads to deal with menstrual blood and a very small number of women were aware about sanitary napkin. However, with rising awareness sanitary napkin has become one of the most popular feminine hygiene product. Sanitary napkins have seen a tremendous product evolution from a sanitary belt in the 20th century to today’s disposable pads.

Highlights of the global sanitary napkin market:

• Improved economic conditions have led to the availability and affordability of sanitary napkins.
• Menstrual pad is the most popular product type.
• Asia-Pacific represents the largest market, followed by Europe.

Various government and NGO entities have initiated projects to spread awareness about feminine hygiene, especially in the developing nations. This has increased the demand for sanitary napkin in these regions. In line with this, manufactures are producing low-cost products. They are also focussing on product diversification, thereby expanding the consumer-base for sanitary napkins in both the developed and developing regions. The market is also being driven by aggressive promotions and marketing strategies adapted by the major players. Increasing disposable income of consumers and organised retail market are some of the other factors leading to a rise in the demand for premium products. Owing to the aforementioned factors, the market is projected to reach a value of more than US$ 18 Billon, exhibiting a CAGR of around 4%.

The global sanitary napkin market is segmented on the basis of product type, including menstrual pad and pantyliner. Amongst these, menstrual pad dominates the market, representing the most popular type. The report has also segmented the market on the basis of distribution channel, including supermarkets and hypermarkets, pharmacies, convenience stores, etc. Region-wise, Asia-Pacific represents the largest market on account of an expanding consumer-base. Other regions include Europe, North America, Latin America, and Middle East and Africa. On evaluating the competitive landscape, it is found that Procter & Gamble, Hengan International Group Company Limited, Kimberly-Clark Corporation, Edgewell Personal Care Company and Kao Corporation are the key players operative in the market.

Read full report with TOC @ http://www.imarcgroup.com/sanitary-napkin-market

The report by IMARC Group has examined the global sanitary napkin market on the basis of:

Type:

• Menstrual Pad
• Pantyliner

Distribution Channel:

• Supermarkets and hypermarkets
• Pharmacies
• Convenience stores
• Others

Region:

• Asia-Pacific
• Europe
• North America
• Latin America
• Middle East and Africa

Key Players:

• Procter & Gamble
• Hengan International Group Company Limited
• Kimberly-Clark Corporation
• Edgewell Personal Care Company
• Kao Corporation

Browse related reports :

Bath Soap Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Perfume Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Global Vision Care Market Overview 2017, Demand by Regions, Share and Forecast 2017 to 2022

The global vision care market has witnessed a moderate growth over the past few years. Some of the major driving factors include growing geriatric population, sedentary lifestyle, constant exposure to electronic screens and increasing cases of eye disorders.

Request sample report: http://www.imarcgroup.com/request?type=report&id=846&flag=B

IMARC Group’s latest report, titled “Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global vision care market reached a value of US$ 54 Billion in 2016. Eyes are organs which provide vision to human beings so as to process visual details. Vision is vital for performing daily activities such as reading, watching, writing, playing, etc. Changing lifestyles, increasing pollution, unhealthy eating habits, etc. have resulted in a gradual rise in the number of eye complications such as conjunctivitis, myopia, diabetic retinopathy, astigmatism, macular edema, hyperopia, retinal tears and optic neuritis. This has resulted in the development of vision care products and treatments, over the past few years.

Highlights of the global vision care market:

• Increasing incidences of eye problems and sedentary lifestyle are the major drivers of the vision care market.
• On the basis of product type, glass lenses account for the majority of the market share.
• North America holds for the majority of the global share, representing the largest market.

Expanding geriatric population and a surge in the cases of eye disorders and diseases worldwide are the primary growth-inducing factors for the market. Around 285 million people across the globe are visually impaired, out of which 246 million have low vision as a result of unhealthy diet and lifestyle dominated by constant use of electronic devices such as mobiles, laptops, tablets, computers, etc. Owing to these factors, an upsurge has been witnessed in the growth of the market. Beside this, exposure to airborne dust and other contaminants also affect the vision, thereby, contributing to the growth aspects of the vision care market. Moreover, rising brand consciousness among the consumers coupled with surging income levels have led them to opt for better quality products. According to the report, the market is further expected to reach a value of US$ 66 Billion by 2022, exhibiting a CAGR of more than 3% during 2017-2022.

The market has been segmented on the basis of type, wherein glass lenses account for the majority of the global market share. They are followed by contact lenses, intraocular lenses, contact solutions, lasik equipment and artificial tear. The market is further segregated on the basis of distribution channels into retail stores, online stores, clinics and hospitals. Amongst these, retail stores hold the majority of the total sales. Region-wise, North America represents the leading market, followed by Europe, Asia Pacific, Latin America, and Middle East and Africa. On analysing the competitive landscape of the market, it is found that Johnson & Johnson, Cooper, Valeant Pharmaceuticals, Essilor, and Novartis AG are the key players.

Read full report with TOC: http://www.imarcgroup.com/vision-care-market

The report has examined the global vision care market on the basis of:

Product Type:

• Glass Lenses
• Contact Lenses
• Intraocular Lenses
• Contact Solutions
• Lasik Equipment
• Artificial Tear

Distribution Channel:

• Retail Stores
• Online Stores
• Clinics
• Hospitals

Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Major Manufacturers:

• Johnson & Johnson
• Cooper
• Valeant Pharmaceuticals
• Essilor
• Novartis AG

Browse related reports:

Artificial Organs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Breast Pump Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

USA: +1-631-791-1145

Email: sales@imarcgroup.com

Website: http://www.imarcgroup.com

Follow us on twitter: @imarcglobal

Global Artificial Organs Market Overview 2017, Demand by Regions, Share and Forecast to 2022

The global artificial organs market has been witnessing a healthy growth. This can be attributed to ageing population, rising number of road accidents, scarcity of organ donors, advancements in the technology, etc.

Request sample report @ http://www.imarcgroup.com/request?type=report&id=833&flag=B

The latest report by IMARC Group, titled “Artificial Organs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global artificial organs market reached a value of more than US$ 12 Billion in 2016. Artificial organs are man-made electrical devices that are integrated into a human body so as to replace a damaged or missing natural organ. They are composed of plastic that is seeded with stem cells from the transplant recipient, due to which the body’s immune system does not reject the artificial organ. These bio-artificial devices can temporarily or permanently substitute organs and provide support for restoring a specific function so that the patient can heal rapidly. Artificial organs include pacemaker, artificial heart and artificial substitutes for missing limbs or performing kidney functions.

Highlights of the global artificial organs market:

• Ageing population and growing cases of chronic diseases are major growth driving factors.
• Artificial kidney represents the most popular product type, leading the artificial organs market.
• North America represents the largest market, holding the majority of the global share.

A rise in geriatric population, growing prevalence of chronic diseases and a surge in the number of people suffering from organ failures and limb amputation are the major growth-inducing factors for the artificial organs market. Further, unavailability of organ donors at the time of requirement coupled with growing public awareness about the advancements in the healthcare sector are contributing to the growth of the market. As a result of rising incidences of road accidents and injuries leading to amputations, the demand for artificial organs has further increased. Furthermore, advancements in technological innovations to develop affordable artificial organs are also projected to aid the market growth. According to the report, the market is expected to reach a value of more than US$ 20 Billion by 2022, exhibiting a CAGR of nearly 7% during 2017-2022.

On the basis of key applications, artificial kidney represents the largest product type. Other major product types include artificial heart, cochlear implants and artificial pancreas. On the basis of region, North America represents the largest market for artificial organs, accounting for the majority of the total global share. Other major regions include Europe, Asia-Pacific, Latin America, and Middle East and Africa. On evaluating the competitive landscape of the market, it is found that the key players include Abiomed, Inc., Heartware International, Inc., Edwards Lifesciences Corp, Boston Scientific Corporation and Cochlear Limited.

Read full report with TOC @ http://www.imarcgroup.com/artificial-organs-market

The report by IMARC Group has examined the global artificial organs market on the basis of:

Type:

• Artificial Kidney
• Artificial Heart
• Artificial Pancreas
• Cochlear Implants
• Others

Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Major manufacturers:

• Abiomed, Inc.
• Heartware International, Inc.
• Edwards Lifesciences Corp
• Boston Scientific Corporation
• Cochlear Limited

Browse related reports:

Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Breast Pump Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com

Follow us on twitter: @imarcglobal

Global Breast Pump Market Overview 2017: Growth, Demand and Forecast Research Report to 2022

The global breast pump market has witnessed a positive growth over the past several years. This can be accredited to growing number of working women, inflating disposable incomes, technological advancements and growing acceptance of breast pumps across the world.

Request sample report: http://www.imarcgroup.com/request?type=report&id=855&flag=B

According to IMARC Group’s latest report, titled “Breast Pump Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the global breast pump market reached a value of US$ 642 Million in 2016. Breast pump is a mechanical device that extracts milk from the breasts of a lactating woman by using suction which triggers the milk ejection. The application of breast pump prevents discomfort and the expressed milk can be used to feed to the baby later, as per the need. This device is highly useful for women who are not able to nurse their babies constantly. Additionally, a breast pump can also be used to stimulate lactation for women with a low milk supply. Breast pumps include manual devices driven by hand or foot movement, or electrical devices powered by batteries.

Highlights of the global breast pump market:

• Growing number of working women has fueled the global breast pump market.
• Battery-powered breast pump accounts for the majority of the market share.
• North America represents the leading market.

The global breast pump market is driven by growing women employment rate. A majority of working women resume work immediately after giving birth, resulting in busy schedules and hectic lifestyles. In order to meet the basic requirements of babies, more and more women are adopting breast pumps to store and provide breastmilk as and when needed. Moreover, growing awareness about the benefits of breast milk and importance of breastfeeding has stimulated the demand for breast pumps globally. Additionally, technological advancements have encouraged the manufacturers to come up with advanced products, such as double breast pumps, which has widened the consumer base. Some of the other factors driving the growth of the global breast pump market are government initiatives towards consumer awareness and improving healthcare infrastructure, especially in the emerging economies. Owing to the abovementioned factors, the market is expected to reach a value of US$ 972 Million in 2022, exhibiting a CAGR of around 7% during 2017-2022.

The global breast pump market is segmented on the basis of type, including closed system breast pump and open system breast pump. On the basis of technology, battery-powered breast pump account for the majority of the market share, followed by electric breast pump and manual breast pump. The market is also segmented on the basis of application, into hospital and personal care. Region-wise, North America represents the largest market, accounting for the majority of the total share. North America is followed by Europe, Asia-Pacific, Latin America, and Middle East and Africa. On evaluating the competitive landscape of the market, it is found that Philips Avent, Pigeon Corporation, Medela, Ameda and Hygeia Medical Group II are the key global players.

Read full report with TOC: http://www.imarcgroup.com/breast-pump-market

The report by IMARC Group has examined the global breast pump market on the basis of:

Type:

• Closed System Breast Pump
• Open System Breast Pump

Technology:

• Battery-Powered Breast Pump
• Electric Breast Pump
• Manual Breast Pump

Application:

• Hospital
• Personal Care

Regions:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Key Players:

• Philips Avent
• Pigeon Corporation
• Medela
• Ameda
• Hygeia Medical Group II

Browse related reports:

Artificial Organs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Global Generic Drugs Market Size, Share, Price Trends, Forcast 2017-2022

The global generic drugs market has witnessed a rapid growth in recent years. Some of the factors which have helped in the market growth of generic drugs are their performance characteristics, cost-effectiveness, reduced investments in R&D, patent expiry of the branded drugs, etc.

The latest report by IMARC Group titled, “Generic Drugs Market: Global Industry Trends, Manufacturing Process, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global generic drugs market reached a value of nearly US$ 230 Billion in 2016, growing at a CAGR of more than 7% during 2010-2016. Generic drugs have the same active ingredients and possess similar performance characteristics as their branded variants, such as strength, quality, form, effect, intended use, side effects, route of administration, therapeutic effect, etc. These drugs are manufactured under the same rules and regulations of manufacturing practices required for branded drugs. However, they are sold under their chemical names rather than the brand names.

Request sample of the report: http://www.imarcgroup.com/request?type=report&id=549&flag=B

Highlights of the global generic drugs market:

• The market is driven primarily by their affordability.
• The USA represents the largest market for these drugs, accounting for the majority of the share.
• The market is expected to reach a value of around US$ 360 Billion by 2022.

To get more information, please visit @ http://www.imarcgroup.com/generic-drug-manufacturing-plant

The cost-effectiveness of the generic drugs has emerged as one of the major factors which has contributed in influencing the growth of the market. These drugs require low investments in research & development, which brings down the cost of manufacturing significantly. This has encouraged the government and third-party payers to promote the manufacturing of these drugs and save billions of dollars on healthcare expenditures. Apart from this, the patent expiry of the branded drugs is also an essential factor which provides encouragement to the generic drugs market. Most branded drugs come with a lifespan of 20 years during which other manufacturers cannot sell the branded drugs under their companies’ name. However, when the patent protection expires, the manufacturing rights of these drugs is available to the other manufacturers. Some of the other growth inducing factors include rising aging-population, increasing prevalence of chronic diseases, and incentives offered to physicians and pharmacists to promote generics. Further, the market is expected to reach a value of nearly US$ 360 Billion by 2022.

The report has segmented the market on a regional basis. Some of the major markets for generic drugs include USA, China, Brazil, Germany and France. Amongst these, USA is the largest market, accounting for the majority of the share. An analysis of the competitive landscape provides the details of the key players operative in the market. Some of the major players are Teva Pharmaceuticals, Novartis–Sandoz, Mylan, Freseunis, and Hospira.

The report has examined the global generic drugs market on the basis of:

Key Regions:

• USA
• China
• Brazil
• Germany
• France

Key Players:

• Teva Pharmaceuticals
• Novartis - Sandoz
• Mylan
• Freseunis
• Hospira

Browse more related reports:

US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

Tel No: +1-631-791-1145

Email: sales@imarcgroup.com

Website: http://www.imarcgroup.com

Follow us on twitter: @imarcglobal

Canada Generic Drug Market Share, Size , Price Trends and Forecast 2017-2022

The Canada generic drug market has witnessed a significant growth over the past several years, reaching a volume of around 0.46 Billion Units in 2016. This can be attributed to public and private sector drugs programs and healthcare initiatives promoting the use of generic drugs.

Canada currently represents the ninth-largest generic drug market worldwide, accounting for nearly 3% of the total global share. The share of generic drugs in the pharmaceuticals market has increased significantly over the past several years. At present, generic drugs account for around 70% of the total retail prescriptions, and 22% of the total pharmaceutical sales value in the region. This can be attributed to the various public and private sector drug programs aimed at cost-containment and increasing awareness about generic drugs. The latest report by IMARC Group titled, “Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the Canada generic drug market reached a volume of around 0.46 Billion Units in 2016, growing at a CAGR of around 8% during 2010-2016.

Request sample of the report: http://www.imarcgroup.com/request?type=report&id=700&flag=B

Highlights of the Canada Generic Drug Market:

• Generic drugs account for nearly 70% of the total retail prescriptions in Canada.
• Changing demographics and government initiatives are the major growth drivers.
• Patent expiry of a number of blockbuster drugs is expected to provide growth opportunities.

Population growth, changing demographics, increasing prevalence of chronic diseases and a rise in the use of drug therapy are projected to put more pressure on Government healthcare initiatives such as the ‘drug benefit plans’ operative in the Canadian territories and provinces. As the sustainability of these programmes is largely dependent on the use of generic drugs, the demand for these drugs is expected to increase over the next several years. Moreover, the patent expiry of a number of blockbuster drugs is also anticipated to expand the generic drug market in Canada. According to the report, the market is further expected to reach a volume of nearly 0.7 Billion Units by 2022.

To get more infromation, please visit @ http://www.imarcgroup.com/canada-generic-drug-market

The report analyses the competitive landscape of the market and provides details of the major players in the market. Some of these include Teva Pharmaceutical Ltd., Apotex Inc., Snadoz Canada, Actavis, Mylan, Pharmascience Inc., Taro Pharmaceuticals, Novartis, Ranbaxy Pharmaceuticals Canada and Hospira. The report provides a comprehensive insight into the historical and current trends as well as the future prospects of the generic drug market in Canada. This study serves as an exceptional tool to understand the sales trends, volume trends, growth, key segments, competitive structure, regulations, major manufacturer, major distributors, top drugs, manufacturing requirements, opportunities and future prospects of the Canada generic drug market. This report can serve as an excellent guide for manufacturers, consultants, researchers, marketing strategists and all those who plan to foray into the Canada generic drug market in any form.

Browse more related reports:

Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2017-2022

Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

Tel No: +1-631-791-1145

Email: sales@imarcgroup.com

Website: http://www.imarcgroup.com

Follow us on twitter: @imarcglobal

Brazil Generic Drug Market Share, Size , Price Trends and Forecast 2017-2022

Brazil generic drug market has grown at a CAGR of 15% during 2010-2016. Some of the factors which have facilitated the market growth include government initiatives, increase in aging-population and growth in the rate of lifestyle diseases.

The latest report by IMARC Group titled, “Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2017-2022”, finds that the Brazil generic drug market reached a value of more than US$ 80 Billion in 2016, growing at a CAGR of around 15% during 2010-2016. In 1999, a law was passed by the government of Brazil – The Generic Drugs Law – which allowed the substitution of generic drugs for trademark branded drugs. This law authorized laboratories to handle and sell drugs, thereby enabling commercialisation and availability of previously more expensive branded drugs after the expiry of their patents. This has helped in improving the quality of drugs and facilitating the consumers to access quality drug treatment.

Request sample of the report: http://www.imarcgroup.com/request?type=report&id=696&flag=B

Highlights of Brazil generic drug market:

• The Generic Drugs Law gave impetus to the market and helped in improving the quality of the generic drugs.
• Free distribution of medicines for the treatment of various diseases by the government and public health system provide stimulus for the market growth.
• The factors such as increasing aging-population and growing lifestyle diseases have further driven the demand for generic drugs in the region.

The Brazilian generic drug market has been spurred by the active participation of the government and health-care organizations. Besides passing the Generic Drugs Law, the government has also made constant efforts in promoting the sales of generic drugs. Most importantly, The Brazilian Federal Government represents the biggest pharmaceutical client itself. It distributes free contraceptives and medicines for hypertension, asthma, diabetes, Parkinson's, glaucoma, osteoporosis and rhinitis through their programmes and initiatives. Moreover, the Brazilian public health system; the Sistema Único de Saúde, avails generic versions of the medicines for the treatment of various diseases such as AIDS, tuberculosis, Alzheimer, Hepatitis, transplants, Lupus, etc. Some of the other factors which have contributed in influencing the market include an increase in the aging-population and the growing prevalence of lifestyle diseases. Considering the developments, the market is further expected to reach a value of almost US$ 190 Billion by 2022.

To get more infromation, please visit @ http://www.imarcgroup.com/brazil-generic-drug-market

The report examines the competitive landscape of the market and provides the details of the major players of the market such as EMS S.A., Sanofi Group, Eurofarma Laboratórios S.A., Hypermarcas S.A., Sandoz, Ache Laboratories and União Química Farmacêutica Nacional S.A. The report also provides an in-depth analysis on the historical, current and future trends in the generic drug market in Brazil. This research report serves as an exceptional tool to understand the drivers, sales trends, volume trends, market structure, competitive landscape, regulations, key players, manufacturing and the outlook of generic drugs in Brazil. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the market for generic drugs in Brazil.

Browse more related reports:

Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

Tel No: +1-631-791-1145

Email: sales@imarcgroup.com

Website: http://www.imarcgroup.com

Follow us on twitter: @imarcglobal